Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study
Noémie Topalian(Luxembourg Institute of Health), Gloria Aguayo, Chloé Amouyal(Inserm), Jean‐Baptiste Julla(Centre National de la Recherche Scientifique), Jean‐Pierre Riveline(Inserm), Nicolas Chevalier(Inserm), Lucien Marchand(Lyon 1 Université), Emmanuel Cosson(Hôpital Jean-Verdier), Kalliopi Bilariki(Centre Hospitalier Compiègne-Noyon), Guy Fagherazzi(Luxembourg Institute of Health), E. Sonnet(Centre Hospitalier Régional Universitaire de Brest), Laurence Salle(Inserm), Sylvie Picard(Center Point), Dulce Canha(University of Luxembourg), Sophie Borot(Université de Franche-Comté), Emmanuelle Sokol(Institut Curie), I. Banu(Hôpital Paris Saint-Joseph), Sandrine Lablanche(Inserm), D. Gouet, Aurélie Berot(Centre Hospitalier Universitaire de Reims)
Cited by 1
Related Papers
Human Health and Ocean Pollution
|Annals of Global Health|2020|751
Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC)
|American Journal of Clinical Nutrition|2015|360
Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study
|American Journal of Clinical Nutrition|2012|327
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial
|Diabetes Care|2019|282
Bisphenol A: An endocrine and metabolic disruptor
|Annales d Endocrinologie|2013|278